Literature DB >> 30188783

Low-Fat Abiraterone Food Effect Is of Great Consequence.

Ian F Tannock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30188783     DOI： 10.1200/JCO.2018.79.2358

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.

Authors:  Caroline S Clarke; Rachael M Hunter; Andrea Gabrio; Christopher D Brawley; Fiona C Ingleby; David P Dearnaley; David Matheson; Gerhardt Attard; Hannah L Rush; Rob J Jones; William Cross; Chris Parker; J Martin Russell; Robin Millman; Silke Gillessen; Zafar Malik; Jason F Lester; James Wylie; Noel W Clarke; Mahesh K B Parmar; Matthew R Sydes; Nicholas D James
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

2.  Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.

Authors:  Amol Patel; Ian F Tannock; Priyanka Srivastava; Bivas Biswas; Vineet Govinda Gupta; Atul Batra; Sainath Bhethanabhotla; Raja Pramanik; Shubh Mahindru; Tvsvgk Tilak; Chandan Krishna Das; Prashant Mehta
Journal:  JCO Glob Oncol       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.